Pharmaceutical Companies

"With their broad understanding of regulatory led drug development, Calcis have successfully facilitated a number of initiatives focused on capture, sharing and leverage of information and knowledge to support a learning environment. They demonstrated a flexible approach to align with our needs and timelines and were at ease with all functions and levels within our company".

Michael O'Flynn, Regulatory Programme Director, AstraZeneca, UK.

"Calcis helped us capitalise on our strengths to better position the company to meet its business objectives. By translating innovative ideas into effective working practices, Calcis successfully reshaped product development & licensing processes. Trusted and respected by staff and management, Calcis made a real and lasting difference to the way we work at all levels in the company".

Thor-Björn Conradson, Senior VP International Product Development, Nycomed, Denmark

"Their breadth of pharma experience and creative approach enables them to rapidly understand our issues and develop practical solutions that have a real business value. Calcis is a trusted partner that demonstrates a genuine focus on client needs".

Mike Doherty, Global Head of Regulatory Affairs, Roche, Switzerland.

"By developing and implementing innovative, user-friendly intranet support tools, Calcis helped us to rapidly define, communicate and centralise information for key clinical development processes".

Government & Professional bodies

"All the Calcis training we have commissioned has been very professional and well planned. The courses they delivered were tailor-made for clinical research managers and we have received very positive feedback from them on the courses".

The Pharmaceutical Information Center Ltd, Helsinki, Finland (LÄÄKETIETOKESKUS OY)

Further references are available on request.